CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Amortization of Intangible Assets in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Charles River Laboratories International, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2010 to Q3 2024.
  • Charles River Laboratories International, Inc. Amortization of Intangible Assets for the quarter ending September 28, 2024 was $32.4M, a 5.34% decline year-over-year.
  • Charles River Laboratories International, Inc. Amortization of Intangible Assets for the twelve months ending September 28, 2024 was $131M, a 5.46% decline year-over-year.
  • Charles River Laboratories International, Inc. annual Amortization of Intangible Assets for 2023 was $137M, a 6.23% decline from 2022.
  • Charles River Laboratories International, Inc. annual Amortization of Intangible Assets for 2022 was $147M, a 17.4% increase from 2021.
  • Charles River Laboratories International, Inc. annual Amortization of Intangible Assets for 2021 was $125M, a 11.6% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $131M $32.4M -$1.83M -5.34% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $133M $32.3M -$2M -5.85% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $135M $32.6M -$2.34M -6.71% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $137M $34M -$1.41M -3.99% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-14
Q3 2023 $139M $34.2M -$1.3M -3.67% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $140M $34.3M -$3.33M -8.86% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-07
Q1 2023 $143M $34.9M -$3.09M -8.13% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-09
Q4 2022 $147M $35.4M +$5.24M +17.4% Sep 25, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $141M $35.5M +$2.68M +8.16% Jun 26, 2022 Sep 24, 2022 10-Q 2023-11-08
Q2 2022 $139M $37.6M +$4.63M +14.1% Mar 27, 2022 Jun 25, 2022 10-Q 2023-08-09
Q1 2022 $134M $38M +$9.17M +31.8% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-11
Q4 2021 $125M $30.2M +$2.19M +7.8% Sep 26, 2021 Dec 25, 2021 10-K 2024-02-14
Q3 2021 $123M $32.9M +$4.62M +16.4% Jun 27, 2021 Sep 25, 2021 10-Q 2022-11-02
Q2 2021 $118M $33M +$5.21M +18.8% Mar 28, 2021 Jun 26, 2021 10-Q 2022-08-03
Q1 2021 $113M $28.8M +$963K +3.45% Dec 27, 2020 Mar 27, 2021 10-Q 2022-05-04
Q4 2020 $112M $28M +$4.08M +17.1% Sep 27, 2020 Dec 26, 2020 10-K 2023-02-22
Q3 2020 $108M $28.2M +$4.43M +18.6% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-03
Q2 2020 $103M $27.8M +$5.36M +23.9% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-04
Q1 2020 $98M $27.9M +$8.47M +43.6% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-04
Q4 2019 $89.5M $23.9M +$6.91M +40.6% Sep 29, 2019 Dec 28, 2019 10-K 2022-02-16
Q3 2019 $82.6M $23.8M +$5M +26.6% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-09
Q2 2019 $77.6M $22.4M +$3.66M +19.5% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-05
Q1 2019 $74M $19.4M +$9.14M +89% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-07
Q4 2018 $64.8M $17M +$6.56M +62.7% Sep 30, 2018 Dec 29, 2018 10-K 2021-02-17
Q3 2018 $58.3M $18.8M +$8.45M +81.6% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-06
Q2 2018 $49.8M $18.7M +$8.92M +90.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $40.9M $10.3M -$469K -4.37% Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $41.4M $10.5M -$1.85M -15% Oct 1, 2017 Dec 30, 2017 10-K 2020-02-11
Q3 2017 $43.2M $10.4M -$1.47M -12.4% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $44.7M $9.82M -$1.39M -12.4% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-08
Q1 2017 $46.1M $10.7M +$4.39M +69% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-10
Q4 2016 $41.7M $12.3M +$5.47M +79.9% Sep 25, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $36.2M $11.8M +$5.42M +84.5% Jun 26, 2016 Sep 24, 2016 10-Q 2017-11-09
Q2 2016 $30.8M $11.2M +$5.5M +96.1% Mar 27, 2016 Jun 25, 2016 10-Q 2017-08-09
Q1 2016 $25.3M $6.35M +$1.09M +20.8% Dec 27, 2015 Mar 26, 2016 10-Q 2017-05-10
Q4 2015 $24.2M $6.84M -$300K -4.2% Sep 27, 2015 Dec 26, 2015 10-K 2018-02-13
Q3 2015 $24.5M $6.41M -$1.21M -15.9% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-02
Q2 2015 $25.7M $5.72M -$1.14M -16.6% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-03
Q1 2015 $26.9M $5.26M +$918K +21.2% Dec 28, 2014 Mar 28, 2015 10-Q 2016-05-04
Q4 2014 $26M $7.14M +$2.23M +45.4% Sep 28, 2014 Dec 27, 2014 10-K 2017-02-14
Q3 2014 $23.7M $7.62M +$3.44M +82.3% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 $20.3M $6.85M +$2.39M +53.6% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 $17.9M $4.34M +$91K +2.14% Dec 29, 2013 Mar 29, 2014 10-Q 2015-04-30
Q4 2013 $17.8M $4.91M +$282K +6.09% Sep 29, 2013 Dec 28, 2013 10-K 2016-02-12
Q3 2013 $17.5M $4.18M -$350K -7.73% Jun 30, 2013 Sep 28, 2013 10-Q 2014-10-30
Q2 2013 $17.9M $4.46M +$52K +1.18% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-07
Q1 2013 $17.8M $4.25M -$246K -5.47% Dec 30, 2012 Mar 30, 2013 10-Q 2014-04-30
Q4 2012 $18.1M $4.63M -$710K -13.3% Sep 30, 2012 Dec 29, 2012 10-K 2015-02-17
Q3 2012 $18.8M $4.53M -$747K -14.2% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 $19.5M $4.41M -$1.39M -23.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $20.9M $4.5M -$885K -16.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $21.8M $5.34M -$817K -13.3% Sep 25, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $22.6M $5.28M -$750K -12.4% Jun 26, 2011 Sep 24, 2011 10-Q 2012-11-01
Q2 2011 $23.4M $5.8M +$258K +4.66% Mar 27, 2011 Jun 25, 2011 10-Q 2012-08-07
Q1 2011 $23.1M $5.38M -$1.3M -19.5% Dec 26, 2010 Mar 26, 2011 10-Q 2012-05-04
Q4 2010 $24.4M $6.16M Sep 26, 2010 Dec 25, 2010 10-K 2013-02-27
Q3 2010 $6.03M Jun 27, 2010 Sep 25, 2010 10-Q 2011-11-02
Q2 2010 $5.54M Mar 28, 2010 Jun 26, 2010 10-Q 2011-08-03
Q1 2010 $6.68M Dec 27, 2009 Mar 27, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.